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Vaccine Hesitancy: 
Experimentalism as Regulatory 
Opportunity 
Ana Santos Rutschman* 
Timothy L. Wiemken† 
ABSTRACT 
This issue on patient innovation has prompted us to explore problems related to 
departures from official vaccination schedules. Vaccine confidence has been plum-
meting across the world. In this essay, we argue that a more granular understanding 
of vaccine hesitancy—and ultimately a more finely tuned regulatory framework—
is needed to reflect the current behavioral heterogeneity among indicated patients 
who choose to forego or delay administration of recommended vaccines. In partic-
ular, we focus on a phenomenon we term “vaccine staggering:” a departure from 
vaccination schedules in the form of delays in receiving one or more vaccines, 
which is motivated by the desire to boost the efficacy of each vaccine received by 
a child or adult.1 
 
Current regulatory approaches subsume staggering into vaccine hesitancy frame-
works. The scientific literature, however, has begun to explore possible benefits of 
specific forms of staggering, as well as the need for the production of more infor-
mation on different forms of vaccine staggering. The Essay thus argues in favor of 
separate treatment for vaccine staggering as opposed to vaccine refusal and further 
notes that the current conceptual and regulatory problems surrounding vaccine stag-
gering point to broader systemic issues in vaccination policy and vaccine data in-
frastructure in the United States. 
 
The Essay begins with a brief background section on the evolution of vaccination 
schedules. Part II describes different types of behaviors that may result in departures 
from vaccination schedules, highlighting the disjunction between behavioral heter-
ogeneity and the unified regulatory framework, which currently lumps together ma-
terially different behaviors under the “vaccine hesitancy” umbrella. Part III then 
focuses specifically on the case of vaccine staggering and advocates for a separate 
treatment of staggering behaviors as opposed to other types of departures from of-
ficial vaccination schedules. The Essay further argues that the persistence of unitary 
treatments of vaccine-related behaviors increases uncertainty and promotes 
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 1. See infra, Part III.B.2. 
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conflicting discourses outside scientific circles, an especially concerning phenom-
enon at a time in which outbreaks of vaccine-preventable disease are once again 
becoming more frequent. The Essay concludes by briefly pointing out that the spe-
cific problems surrounding current approaches to vaccine staggering also illustrate 
systemic limitations of the vaccine data infrastructure in the United States. 
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I. VACCINATION SCHEDULES 
Vaccination schedules are timelines of recommended childhood vaccinations 
issued by public health organizations, both at the international and domestic level.2 
The World Health Organization provides recommendations to program managers 
on vaccination schedules, which are then adopted at the national level by the rele-
vant regulatory bodies.3 In the United States, vaccination schedules are set by the 
Centers for Disease Control and Prevention4 upon recommendations from the Ad-
visory Committee on Immunization Practices (“ACIP”), a group of medical and 
public health experts focusing on vaccines and related biopharmaceutical products,5 
which works in consultation with entities like the American Academy of Pediatrics 
and the American Academy of Family Physicians.6 
ACIP’s recommendations include both the types of vaccines recommended for 
different populations and the timeline according to which they should be adminis-
tered— in other words, the schedule. Currently, schedules are divided into three 
categories across an individual’s lifespan: children up to six years old,7 seven to 18 
years old8 and ages 19 and older.9 
In 1994, a federal program—Vaccines for Children—was established to enable 
the CDC to purchase ACIP-recommended vaccines at discount prices and make 
them available to grantees at the state or local level.10 The program covers Medi-
caid-eligible children, uninsured and underinsured children, as well as American 
Indian and Alaska Native children.11 Some ACIP-recommended vaccines for adult 
populations are covered through state Medicaid programs, although there is great 
variation across the United States as to which vaccines are covered by specific 
 
 2. See e.g., CDC Schedules: Recommended Immunization Schedules for Children, Adolescents, and 
Adults (2020), CTRS. FOR DISEASE CONTROL & PREVENTION, https://www.immun-
ize.org/cdc/schedules/ (last visited February 6, 2020). 
 3. See generally WHO recommendations for routine immunization -summary tables, WORLD 
HEALTH ORG., https://www.who.int/immunization/policy/immunization_tables/en/ (last updated Sep-
tember 8, 2020). 
 4. See The Childhood Immunization Schedule, CTRS. FOR DISEASE CONTROL & 
PREVENTION, https://www.cdc.gov/vaccines/hcp/patient-ed/conversations/downloads/vacsafe-child-
immun-bw-office.pdf (last visited February 2013). 
 5. Id. 
 6. KEVIN M. MALONE & ALAN R. HINMAN, LAW IN PUBLIC HEALTH PRACTICE 286 (Richard A. 
Goodman et al. eds., 2003). 
 7. 2020 Recommended Vaccinations for Infants and Children (Birth through 6-years), CTRS. FOR 
DISEASE CONTROL & PREVENTION, https://www.cdc.gov/vaccines/schedules/easy-to-read/child-easy-
read-compliant.html (last modified February 5, 2020). 
 8. 2020 Recommended Vaccinations for Children 7-18 Years Old, CTRS. FOR DISEASE CONTROL & 
PREVENTION, https://www.cdc.gov/vaccines/schedules/easy-to-read/adolescent-easyread-compli-
ant.html (last modified February 3, 2020). 
 9. Recommended Adult Immunization Schedule for ages 19 years or older, United States, 2020, 
CTRS. FOR DISEASE CONTROL & PREVENTION, https://www.cdc.gov/vaccines/schedules/hcp/imz/adult-
compliant.html (last modified February 3, 2020). 
 10. See Quality of Care Vaccines, MEDICAID.GOV, https://www.medicaid.gov/medicaid/quality-of-
care/quality-improvement-initiatives/quality-of-care-vaccines/index.html (last visited October 10, 
2020). 
 11. About VFC: The VFC Program: At a Glance, CTRS. FOR DISEASE CONTROL & PREVENTION, 
https://www.cdc.gov/vaccines/programs/vfc/about/index.html (last modified February 18, 2016). 
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programs.12 In addition to vaccination schedules, the CDC provides additional vac-
cination recommendations for specific populations,13 including travelers,14 racial 
and ethnic populations,15 or vaccines recommended for immigrants and refugees 
coming to the United States.16 
While the federal government operates in an advisory capacity through ACIP’s 
recommendations promoted by the CDC, it cannot impose vaccination require-
ments.17 The ability to mandate vaccination has long been understood as an emana-
tion of the police power of the states,18 which in turn have consistently relied on 
ACIP’s recommendations.19 
Mandatory vaccination has also long been tied to school attendance.20 The first 
law to impose mandatory school vaccination was passed as early as 1850 in Mas-
sachusetts,21 with another ten states following suit by the early twentieth century.22 
In 1922, the Supreme Court upheld the constitutionality of city ordinances exclud-
ing unvaccinated children from attending public schools.23 Recurring measles out-
breaks in the mid-twentieth century eventually led all 50 states to mandate school 
vaccination, starting in 1980-81.24 
The progressive expansion of vaccination mandates throughout the twentieth 
century, however, has not translated into homogenous approaches to vaccination 
policy at the state level. Mandates vary considerably across the country, with an 
overwhelming majority of states allowing some form of non-medical exemption to 
vaccination mandates.25 
Non-medical exemptions are sets of justifications defined by state regulators 
as grounds for the refusal of mandatory vaccination, which are not linked to any 
 
 12. See generally SARA ROSENBAUM ET AL., CENTER FOR HEALTH SERVICES RESEARCH AND POLICY: 
THE GEORGE WASHINGTON UNIVERSITY SCHOOL OF PUBLIC HEALTH AND HEALTH SERVICES, 
MEDICAID COVERAGE OF IMMUNIZATIONS FOR NON-INSTITUTIONALIZED ADULTS (2003), 
 13. See Vaccines and Immunizations: For Specific Groups of People (2016), CTRS. FOR DISEASE 
CONTROL & PREVENTION, https://www.cdc.gov/vaccines/spec-grps.html#conditions (last reviewed May 
17, 2016). 
 14. See Need travel vaccines? Plan ahead., CTRS. FOR DISEASE CONTROL & PREVENTION, 
https://wwwnc.cdc.gov/travel/page/travel-vaccines (last reviewed October 11, 2018). 
 15. See generally Vaccines and Immunizations: For Specific Groups of People supra note 13. 
 16. See Vaccine Information for Adults: Vaccines for Immigrants and Refugees., CTRS. FOR DISEASE 
CONTROL & PREVENTION, https://www.cdc.gov/vaccines/adults/rec-vac/immigrants-refugees.html (last 
reviewed March 27, 2019). 
 17. See MALONE & HINMAN, supra note 6, at 263. 
 18. Jacobson v Massachusetts, 197 US 11, 25 (1905) (recognizing the power of the states to compel 
vaccination). It should be noted that, even prior to the Supreme Court’s decision in 1905, most states 
were already imposing mandatory vaccination to some extent. See Viemester v. White, 72 N.E. 97 (N.Y. 
1904) (finding that a law excluding unvaccinated children from admittance to, and attendance of, public 
schools did not violate articles. 9, § 1 and 1§§ 1 and 6 of the Constitution). 
 19. MALONE & HINMAN, supra note 6, at 268. We address the issue of exemptions to state vaccine 
mandates infra; see note 24 and accompanying text. 
 20. See Jessica Bylander, The United States’ Piecemeal Approach to Vaccine Policy, 35-2 HEALTH 
AFF. 195, 196. (2016). 
 21. Id. 
 22. Daniel E. Salmon et al., Compulsory Vaccination and Conscientious or Philosophical Exemp-
tions: Past, Present, And Future, 367 LANCET 436, 439 (2006). 
 23. Zucht v. King, 260 U.S. 174 (1922) (examining mandatory vaccination in connection with attend-
ance of public schools as well as “other place[s] of education”); see also Viemester v. White, 72 N.E. 97. 
 24. Salmon et al., supra note 22, at 439. 
 25. See generally Eileen Wang et al., Nonmedical Exemptions from School Immunization Require-
ments: A Systematic Review, 104(11) AM. J. PUB. HEALTH e62, e62 (2014). 
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temporary or permanent health conditions.26 The CDC publishes a list of health 
conditions that may render certain vaccines unsuitable for specific individuals.27 
For example, in the case of the MMR vaccine (measles, mumps, rubella)—a vaccine 
that is part of the vaccine schedule for children, typically administered in three 
doses between one and 6 years of age28—the CDC recommends that healthcare pro-
viders evaluate administration of the vaccine to patients suffering from certain 
blood, respiratory and immune system disorders, on a case by case basis: an evalu-
ation that may result in the decision not to give the MMR vaccine to a patient.29 
Temporary conditions such as pregnancy can also result in departures from the 
standard adult vaccination schedule that are endorsed by the CDC.30 These health-
related justifications for not receiving a vaccine, or for delaying vaccination, con-
stitute carve-outs to the overall regime. Both standard vaccination schedules and 
exemptions to the schedule based on medical purposes are endorsed by federal pub-
lic health-oriented agencies (such as the CDC) and professional organizations such 
as the American Academy of Pediatrics, the American Academy of Family Physi-
cians and the American College of Obstetricians and Gynecologists.31 All 50 states 
and the District of Columbia recognize medical exemptions.32 
Until the mid-twentieth century, justifications based on health conditions were 
the only admissible grounds for vaccination exemptions.33 From 1960s onwards, 
however, states began allowing a different type of carve-out by recognizing non-
medical exemptions based on either religious or philosophical beliefs, or both.34 
Religious exemptions initially emerged somewhat narrowly, linked to organized 
religions that object to vaccination— a list that is relatively short and does not in-
clude any of the major organized religions—35but expanded conceptually and 
 
 26. See Vaccines and Preventable Diseases: Who should not get vaccinated with these vaccines?, 
CTRS. FOR DISEASE CONTROL & PREVENTION, https://www.cdc.gov/vaccines/vpd/should-not-vacc.html 
(last reviewed April 2, 2020) (listing different medical conditions in connection with discrete vaccines). 
 27. Id. 
 28. Vaccines and Preventable Diseases: Measles, Mumps, and Rubella (MMR) Vaccination: What 
Everyone Should Know, CTRS. FOR DISEASE CONTROL & PREVENTION, https://www.cdc.gov/vac-
cines/vpd/mmr/public/index.html (last reviewed March 28, 2019). 
 29. Id. 
 30. See Pregnancy and Vaccination: Guidelines for Vaccinating Pregnant Women, CTRS. FOR 
DISEASE CONTROL & PREVENTION, https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/guide-
lines.html (last updated August 31, 2016) (listing, among others, the human papillomavirus as “not rec-
ommended” and the MMR vaccine as “contraindicated” during pregnancy, whereas inactivated influ-
enza vaccines are “recommended” during pregnancy). 
 31. See Recommended Child And Adolescent Immunization Schedule for ages 18 years or younger, 
CTRS. FOR DISEASE CONTROL & PREVENTION, https://www.cdc.gov/vaccines/schedules/down-
loads/child/0-18yrs-child-combined-schedule.pdf (last updated January 1, 2020).. 
 32. SchoolVaxView: What is an Exemption and What Does it Mean?, CTRS. FOR DISEASE CONTROL 
& PREVENTION, https://www.cdc.gov/vaccines/imz-managers/coverage/schoolvaxview/require-
ments/exemption.html (last reviewed October 12, 2017); see also Tiffany L. Wang et al., Mandatory 
Influenza Vaccination for All Healthcare Personnel: A Review on Justification, Implementation and Ef-
fectiveness, 29 CURR. OPIN. PEDIATR. 606 (2017): Guglielmo Dini et al., Influenza Vaccination in 
Healthcare Workers: A Comprehensive Critical Appraisal of the Literature, 14(3) HUM. VACC. 
IMMUNOTHER. 772, 784 (2018); Samantha Pitts et al., A Systematic Review of Mandatory Influenza Vac-
cination in Healthcare Personnel, 47 AM. J. PREV. MED. 330, 331 (2014). 
 33. See generally James Colgrove & Abigail Lowin, A Tale of Two States: Mississippi, West Virginia, 
And Exemptions To Compulsory School Vaccination Laws, 35:2 HEALTH AFF. 348, 352 (2016), 
https://www.ncbi.nlm.nih.gov/pubmed/26858391 
 34. Id. at 349-350 
 35. See, e.g., Miriam Krule, Why Is There a Religious Exemption for Vaccinations?, SLATE (Feb. 5, 
2015, 3:23 PM), https://slate.com/technology/2015/02/religious-exemption-for-vaccines-christian-
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through case law to encompass situations in which an individual claims “sincerely 
held beliefs,” requiring exemption.36 In addition to religious exemptions, some 
states allow for exemptions based on personal beliefs, also known as philosophical 
exemptions.37 By mid-2020, 45 states and the District of Columbia recognized some 
form of non-medical exemption.38 
As we further detail in the following section, the relationship between non-
medical exemptions and the proliferation of infectious diseases is well established: 
the CDC points out that “[s]tudies have shown that vaccine exemptions tend to clus-
ter geographically, making some communities at greater risk for outbreaks.”39 
II. DEPARTURES FROM VACCINATION SCHEDULES 
A. Public Health Problems Associated with Departure from 
Vaccination Schedules 
Robust adherence to vaccination practices—including following vaccination 
schedules—has long been considered a key practice in contemporary public 
health.40 Yet, in recent years, levels of vaccine confidence have been declining,41 
prompting the World Health Organization in 2019 to add vaccine hesitancy to the 
list of ten greatest threats to global public health.42 
As explained in the following section, the concept of vaccine hesitancy encom-
passes a broad array of materially distinguishable behaviors, which may result in 
either delays or the non-administration of recommended vaccines to indicated pop-
ulations.43 Both delays in vaccine administration and—especially—vaccine refusal 
can trigger significant individual and public health consequences. A study looking 
at nationwide surveillance data collected between 1985 and 1992 showed that the 
 
scientists-catholics-and-dutch-reform-church.html; Ginia Bellafante, Why Are There Religious Exemp-
tions for Vaccines?, N.Y. TIMES (Apr. 12, 2019), https://www.nytimes.com/2019/04/12/nyregion/mea-
sles-vaccines-religious-exemptions.html. Christian Science is one of the very few religions that advo-
cates for “praying for healing” as opposed to reliance on vaccination, but it characterizes its own ap-
proach to vaccination by stating that “our practice isn’t a dogmatic thing [in the area of vaccination].” 
See CHRISTIAN SCIENCE, A CHRISTIAN SCIENCE PERSPECTIVE ON VACCINATION AND PUBLIC HEALTH, 
https://www.christianscience.com/press-room/a-christian-science-perspective-on-vaccination-and-pub-
lic-health 
 36. See Dalli v. Bd. of Educ., 267 N.E.2d 219, 222 (1971). 
 37. States With Religious and Philosophical Exemptions From School Immunization Requirements, 
NAT’L CONFERENCE OF ST. LEGIS., https://www.ncsl.org/research/health/school-immunization-exemp-
tion-state-laws.aspx (June 6, 2020). 
 38. Id. 
 39. For Immunization Managers: State Vaccination Requirements, CTRS. DISEASE CONTROL & 
PREVENTION, https://www.cdc.gov/vaccines/imz-managers/laws/state-reqs.html (last reviewed Novem-
ber 15, 2016); see also Saad B. Omer et al., Geographic Clustering of Nonmedical Exemptions to School 
Immunization Requirements and Associations with Geographic Clustering of Pertussis, 168 AM. J. 
EPIDEMIOLOGY 1389, 1390 (2008); Y. Tony Yang et al., Sociodemographic Predictors of Vaccination 
Exemptions on the Basis of Personal Belief in California, 106 AM. J. PUB. HEALTH 172, 173 (2016). 
 40. See generally Sandra W. Roush et al., Historical Comparisons of Morbidity and Mortality for 
Vaccine-Preventable Diseases in the United States, 298(18) J. AM. MED. ASS’N 2155, 2156 (2007). 
 41. See Heidi J. Larson, The State of Vaccine Confidence, 392 LANCET 2244, 2244 (2018). 
 42. Ten threats to global health in 2019, WORLD HEALTH ORG., https://www.who.int/news-room/fea-
ture-stories/ten-threats-to-global-health-in-2019 (last visited November 29, 2020). 
 43. Infra, Part II.B. 
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risk of contracting measles faced by children exempted from vaccination was 35 
times higher than the risk faced by non-exempted children.44 
B. Regulatory Problems Associated Posed by Departures 
from Vaccination Schedules 
1. A Conceptual Blur 
Setting aside the case of non-vaccination attributable to medical conditions, 
other forms of departure from vaccination schedules are highly heterogenous, often 
resting on motivations that are yet not fully understood.45 As seen above, from a 
legal perspective, these departures fall (somewhat too neatly) into two categories: 
religious or philosophical.46 In practice, the motives leading to refusal of, or delays 
in, vaccination, as well as the forms through which departure from vaccination 
schedules occur, are manifold and not properly captured in our regulatory and pol-
icy approaches to vaccination.47 
One of the recurring expressions used to describe departures from vaccination 
schedules that are not linked to medical conditions is “vaccine hesitancy.”48 While 
in widespread currency in different milieus, from the scientific community49 to the 
popular press,50 the expression is employed with some degree of variation, leading 
to a lack of uniformity in shared understandings of which behaviors follow under 
the umbrella of hesitancy. In the following sections, we map out the most common 
usages of the concept of hesitancy and proceed to argue that current applications of 
the concept lack granularity. 
2. Vaccine Refusal 
Vaccine refusal refers to the intentional rejection of a recommended vaccine, 
absent any health conditions that render vaccination contraindicated.51 In the con-
text of childhood vaccination, refusal consists in parental rejection of vaccinations 
 
 44. See D. A. Salmon et al., Health Consequences of Religious and Philosophical Exemptions from 
Immunization Laws: Individual and Societal Risk of Measles, 282 J. AM. MED. ASS’N. 47, 50 (1999). 
 45. See Saad B. Omer et al., Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-
Preventable Diseases, 360:19 N. ENGL. J. MED. 1981, 1983 (2009). 
 46. Supra, Part I. 
 47. See Daniel A. Salmon et al, Vaccine Hesitancy: Causes, Consequences, and a Call to Action, 33 
VACCINE D66, D67 (2015). 
 48. See generally Noni E. MacDonald et al., Vaccine Hesitancy: Definition, Scope and Determinants, 
33 VACCINE 4161, 4161-62 (2015); Catherine C. McClure et al., Vaccine Hesitancy: Where We Are and 
Where We Are Going, 39 CLIN. THER. 1550, 1551 (2017); Eve Dubé et al., Vaccine Hesitancy: An Over-
view, 9 HUM. VACCINE IMMUNOTHER. 1763, 1763-64 (2013); Robert M. Jacobson et al., Vaccine Hesi-
tancy, 90 MAYO CLIN. PROC. 1562, 1563 (2015); Tara C. Smith, Vaccine Rejection and Hesitancy: A 
Review and Call to Action, 4:3 OPEN FORUM INFECT. DIS. at 1, 4 (2017). 
 49. See, e.g. MacDonald, supra note 48., McClure, supra note 48; Dubé, supra note 48; Jacobson, 
supra note 48; Smith, supra note 48. 
 50. See Amelia Harnish, Fighting Vaccine Hesitancy, One Parent at a Time, N.Y. TIMES (Apr. 19, 
2020), https://www.nytimes.com/2020/04/19/parenting/measles-vaccine-hesitancy.html. 
 51. See generally Andrzej Grzybowski et al., Vaccination Refusal. Autonomy and Permitted Coercion, 
11 PATHOGENS & GLOBAL HEALTH 200 (2017) (discussing the necessity of vaccine obligations in the 
United States and Europe). 
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included on the infant and childhood schedules applicable to a particular child, ab-
sent any health conditions that render vaccination contraindicated.52 
Vaccine rejectors intentionally forego (or have their children forego) the op-
portunity to receive a vaccine for which they are indicated.53 Several outbreaks of 
infectious diseases across the United States in the early twenty-first century have 
been linked to growing levels of vaccine refusal.54 For example, in a 2014 measles 
outbreak traced back to Disneyland in California, almost half of the 111 people for 
which a measles infection was reported had deliberately refused vaccination.55 Sim-
ilarly, in 2019, large measles outbreaks in New York and New Jersey were linked 
to significant levels of vaccine refusal among indicated members of a community.56 
As noted above, growing pockets of unvaccinated populations are increasing 
the risk of outbreaks of several infectious disease pathogens, and pose intractable 
challenges to public health policy. So far, 47 states still allow for some form of non-
medical exemption—as of mid-2020, the states that only admit medical exemptions 
are Mississippi, West Virginia57 and, more recently, California.58 Following the 
2019 measles outbreaks, New York has eliminated religious exemptions.59 
3. Vaccine Hesitancy 
In their study of parental concerns leading to departure from vaccination sched-
ules, Hagood and Herlihy propose breaking down the concept of vaccine hesitancy 
into three categories: “vaccine rejectors,” “vaccine resistant” and “vaccine hesitant” 
parents.60 Vaccine rejectors are defined as parents who are “unyieldingly en-
trenched in their refusal to consider vaccine information.”61 Vaccine resistant 
 
 52. See generally Smith, supra note 48; Varun K. Phadke et al., Association Between Vaccine Refusal 
and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis, 315 J. AM. 
MED. ASS’N. 1149, 1150 (2016); Omer, supra note 45. 
 53. Phadke., supra note 52.. 
 54. Id. at 1151-54. 
 55. Id.; see also,  Morbidity and Mortality Weekly Report: Measles Outbreak — California, Decem-
ber 2014–February 2015, CTRS. DISEASE CONTROL & PREVENTION (Feb. 20, 2015);, 
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a5.htm; Karen Kaplan, Vaccine Refusal 
Helped Fuel Disneyland Measles Outbreak, Study Says, L.A. TIMES (Mar. 16, 2015), 
https://www.latimes.com/science/sciencenow/la-sci-sn-disneyland-measles-under-vaccination-
20150316-story.html 
 56. Robert McDonald et al., Notes from the Field: Measles Outbreaks from Imported Cases in Ortho-
dox Jewish Communities — New York and New Jersey, 2018–2019, CTRS. DISEASE CONTROL & 
PREVENTION (May 17, 2019), https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm; Michelle 
Andrews, Why Measles Hits So Hard Within N.Y. Orthodox Jewish Community, KAISER HEALTH NEWS 
(Mar. 11, 2019), https://khn.org/news/why-measles-hits-so-hard-within-n-y-orthodox-jewish-commu-
nity/; Sharron Otterman & Sean Piccoli, Measles Outbreak: Opposition to Vaccine Extends Well Beyond 
Ultra-Orthodox Jews in N.Y., N.Y. TIMES (May 9, 2019), https://www.nytimes.com/2019/05/09/nyre-
gion/measles-outbreak-ny-schools.html 
 57. See generally Colgrove, supra note 33. 
 58. See Paul L. Delamater et al., Change in Medical Exemptions From Immunization in California 
After Elimination of Personal Belief Exemptions, 318(9) J. AM. MED. ASS’N 863, 863-864 (2017); 
Michelle M. Mello et al., Shifting Vaccination Politics — The End of Personal-Belief Exemptions in 
California, 373:9 N. Engl. J. Med. 785, 785 (2015). 
 59. See David Keppler, New York Ends Religious Exemption to Vaccine Mandates, ASSOCIATED 
PRESS (Jun. 14, 2019), https://apnews.com/cdab615894c24163a7947d67c6874f2f. 
 60. See E. Allison Hagood & Stacy Mintzer Herlihy, Addressing Heterogeneous Parental Concerns 
About Vaccination with a Multiple-Source Model: A Parent and Educator Perspective, 9:8 HUM. 
VACCINES & IMMUNOTHERAPEUTICS 1790, 1790-91 (2013). 
 61. Id., at 1791. 
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parents are those who reject vaccination at a given point in time but are nonetheless 
“willing to consider information regarding the safety and efficacy of vaccines.”62 
Vaccine hesitant parents are those expressing “generalized anxiety about vaccines” 
but who “are not as committed to misinformation about vaccinations” as parents in 
the other two categories.63 
As noted above, we believe that it is important to distinguish between outright 
rejection of vaccination in general (or a specific vaccine) and hesitancy regarding 
the safety and efficacy of vaccines (or of a specific vaccine). While we cannot em-
phasize enough that neither vaccine refusal nor vaccine hesitancy are desirable be-
haviors from a societal and public health perspectives, we argue that the search for 
solutions to curb the rising detrimental public health effects of both refusal and hes-
itancy must recognize de facto patterns at the root of departures from vaccination 
schedules. In Part III, when discussing the phenomenon of vaccine staggering, we 
illustrate how current public policies fail to take into account these material distinc-
tions,64 and connect that failure to systemic lacunas in the vaccine ecosystem, which 
stretch into the field of vaccine R&D and vaccine data collection.65 
We also note that Hagood and Herlihy’s proposed categorizations—which we 
argue require further refinement—were developed as a response to the lack of gran-
ularity in current explanatory models for vaccine hesitancy. As the Authors put it 
when discussing vaccine education: 
Previous models of vaccine education have not addressed differences in levels 
and motives of vaccine concerns in parents. These differences may require changes 
in education approaches based on type of parental concern. Addressing vaccine con-
cerns will require a multi-modal approach involving more than just a pediatrician 
or primary health care provider, as well as more than one educational approach.66 
Hagood and Herlihy’s characterization of vaccine hesitancy is not the only pos-
sible treatment of the concept. In 2016, Paterson and co-authors in the United States 
and the United Kingdom examined vaccine hesitancy, defining it as comprising 
“individuals and groups who delay or refuse vaccines.”67 Siddiqui and others, writ-
ing about hesitancy in the United States in 2013, distinguished between “vaccine 
refusal” and “vaccine hesitancy” as they emphasize that both types of behavior are 
closely linked to “fear of vaccines.”68 At the international level, the World Health 
Organization combines the concepts of delaying vaccination and refusing vaccina-
tion under the umbrella of “vaccine hesitancy:” “delay in acceptance or refusal of 
vaccines despite availability of vaccination services.”69 
 
 62. Id. 
 63. Id. at 1791, 1792. 
 64. Infra, Part III.A. 
 65. Infra, Part III.B. 
 66. Hagood supra note 60, at 1790. 
 67. P. Paterson et al., Vaccine Hesitancy and Healthcare Providers, 34 VACCINE 6700, 6700 (2016). 
 68. Mariam Siddiqui et al., Epidemiology of vaccine hesitancy in the United States, 9:12 HUM. 
VACCINE IMMUNOTHER. 2643, 2643 (2013). 
 69. Improving Vaccination Demand and Addressing Hesitancy, WORLD HEALTH ORG., 
https://www.who.int/immunization/programmes_systems/vaccine_hesitancy/en/ (last updated June 17, 
2020); see also WORLD HEALTH ORG., REPORT OF THE SAGE WORKING GROUP ON VACCINE 
HESITANCY (October 1, 2014), https://www.who.int/immunization/sage/meetings/2014/october/1_Re-
port_WORKING_GROUP_vaccine_hesitancy_final.pdf. 
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4. Problems with Current Definitional Heterogeneity 
Conceptual heterogeneity within vaccine hesitancy is problematic for two rea-
sons. First, given the magnitude of the problems posed by under-vaccination of in-
dicated populations in the twenty-first century, definitional clarity is necessary to 
guide present and future policies. As such, the current definitional variability stands 
in the ways of coherent and holistic approaches in a world where outbreaks of vac-
cine-preventable diseases take place more frequently than in previous decades.70 
Second, definitions that lump together the concepts of vaccine refusal and de-
lays in vaccine administration are particularly problematic in that, in their lack of 
granularity, they risk being potentially misleading, especially in the context of 
childhood vaccinations.71 Sound policy, as well as any prescriptive approaches to 
address under-vaccination problems, should be based on operational definitions that 
accurately reflect the gamut of behavioral heterogeneity in refusal of vaccines and 
departures from vaccination schedules. Moreover, as Shen and Dubey have re-
minded us, “[v]accine-hesitant parents who are on the fence far outnumber vaccine 
refusers.”72 With discourse surrounding vaccination topics being such a polarized 
area,73 by conflating a delay with outright refusal of a vaccine, regulators and poli-
cymakers—as well as practitioners relying on international, federal and state guide-
lines—risk alienating large swaths of under-vaccinated populations who have con-
cerns about the administration of vaccines (or a certain vaccine) but do not identify 
as outright refusers. 
We propose that, at a minimum, regulators and policymakers should recognize 
the difference between vaccine refusal and delays in the administration of vaccines. 
If nothing else, the concept of “vaccine hesitancy” should be reserved for behaviors 
that do not constitute an intentional and outright refusal of vaccines, or of a partic-
ular vaccine. Furthermore, as we will show in Part III, the concept of hesitancy 
needs further refinement, particularly when used for vaccine policy and regulatory 
purposes. 
III. REGULATORY OPPORTUNITY 
A. Addressing Vaccine Hesitancy 
As seen in Part II.A, departures from vaccination schedules, both in the form 
of vaccine refusal and delays in the administration of vaccines, pose growing public 
health problems. In 2019, then-FDA Commissioner Scott Gottlieb suggested that, 
given the broad array of non-medical exemptions granted at state level, the federal 
government might have to play a greater role in the regulation of vaccination 
 
 70. See CTRS. DISEASE CONTROL & PREVENTION, CDC MEDIA STATEMENT: MEASLES CASES IN THE 
U.S. ARE HIGHEST SINCE MEASLES WAS ELIMINATED IN 2000 (Apr. 25, 2019). 
 71. See Marissa Wheeler & Alison M. Buttenheim, Parental Vaccine Concerns, Information Source, 
and Choice of Alternative Immunization Schedules, 9:8 HUM. VACCINE IMMUNOTHER. 1782, 1782 
(2013). 
 72. Shixin (Cindy) Shen & Vinita Dubey, Addressing Vaccine Hesitancy: Clinical Guidance for Pri-
mary Care Physicians Working with Parents, 65: March CAN. FAM. PHYSICIAN 175, 175 (2019). 
 73. See, e.g. Steve P. Calandrillo, Vanishing Vaccinations: Why Are So Many Americans Opting Out 
of Vaccinating Their Children?, 37:2 U. MICH. J. L. REFORM 353, 393 (2004); Ana Schmidt et al., Po-
larization of the Vaccination Debate on Facebook, 36 VACCINE 3606, 3606-07 (2018). 
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schedules.74 This idea, which has been echoed by commentators in the public health 
field,75 has also been met with criticism, both as a matter of legal feasibility,76 and 
as public policy.77 
In this section, we take on a subset of the problems associated with vaccine 
hesitancy (defined as not to include vaccine refusal). Specifically, we examine a 
particular form of delay in the administration of recommended vaccines as a way to 
illustrate the need for greater granularity in approaches to hesitancy—the staggering 
of vaccination due to immunogenicity concerns. This phenomenon, we argue, is 
materially different from other types of delayfor instance, delays attributable to a 
parent indecision as to whether to have a child vaccinated due to concerns with 
vaccine safety; delays attributable to political, legal or other worldviews; or delays 
attributable to parental neglect. 
To be sure, this Essay does not call into question the current scientific consen-
sus; rather, it points to widely acknowledged gaps in current scientific knowledge 
and explains that these gaps are not recognized in current regulatory approaches. 
In Part II.B., we describe the concept of vaccine staggering by contrasting it 
with the concepts of simultaneous administration of vaccines and combination vac-
cines. We argue that vaccine staggering should be treated separately from other 
forms of vaccine hesitancy—and, preferably, without the hesitancy label attached 
to it—both from a regulatory and a policy perspective. Finally, in Part III.C we 
argue that the conceptual and information shortcomings we identify in connection 
with vaccine staggering point to larger problems in United States vaccine ecosys-
tem. 
B. Vaccine Staggering 
1. The Emergence of Combination Vaccines and Simulta-
neous Administration of Vaccines 
The CDC defines combination vaccines as “tak[ing] two or more vaccines that 
could be given individually and put them into one shot.”78 Simultaneous admin-
istration of vaccines refers to giving or receiving more than one vaccine dose at the 
 
 74. Elizabeth Cohen & John Bonifield, FDA Chief: Federal Government Might Step in If States Don’t 
Change Lax Vaccine Laws, CNN (Feb. 20, 2019), https://www.cnn.com/2019/02/20/health/vaccine-ex-
emptions-fda-gottlieb/index.html (quoting Commissioner Gottlieb as stating that “[s]ome states are en-
gaging in such wide exemptions that they’re creating the opportunity for outbreaks on a scale that is 
going to have national implications” and that if “certain states continue down the path that they’re on, I 
think they’re going to force the hand of the federal health agencies”). 
 75. See Scott C. Ratzan et al., States Are Failing on Vaccinations. The Federal Government Must 
Lead, WASH. POST (Mar. 7, 2019), https://www.washingtonpost.com/opinions/states-are-failing-on-vac-
cinations-the-federal-government-must-lead/2019/03/07/1e90ece8-40f5-11e9-922c-
64d6b7840b82_story.html. 
 76. Per the current legal architecture, the states have the power to tailor vaccine mandates, not the 
federal government. See MALONE & HINMAN, supra note 6, at 263. 
 77. See Wendy Parmet, Gottlieb’s Threat of Federal Vaccine Mandates: Questionable Legality, Poor 
Policy, STAT (Feb. 28, 2019), https://www.statnews.com/2019/02/28/gottlieb-federal-action-vaccine-
mandates/. 
 78. Vaccines for Your Children: Combination Vaccines, CTRS. DISEASE CONTROL & PREVENTION, 
COMBINATION VACCINES, https://www.cdc.gov/vaccines/parents/why-vaccinate/combination-vac-
cines.html (last reviewed August 1, 2019). 
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same time, which can occur either through the administration of a combination vac-
cine or the administration of multiple non-combination vaccines at the same time.79 
As of mid-2020, scientific and regulatory guidelines endorse the simultaneous 
administration of some vaccines,80 as well as the administration of combination 
vaccines.81 The Institute for Vaccine Safety at the Johns Hopkins Bloomberg 
School of Public Health summarizes the current guidelines as follows: “Combina-
tion vaccines and simultaneous administration of vaccines currently routinely rec-
ommended to the general population in the U.S. have not been shown to cause any 
other adverse events at a greater rate than their individual vaccine components.”82 
Concerns with simultaneous administration of vaccines (as well administration 
of combination vaccines) arose from the mid-1980s onwards, as the roster of rec-
ommended childhood immunizations grew.83 Many of these concerns were linked 
adverse events associated with the administration of vaccines that may induce fe-
ver,84 and in particular to the (rare) possibility of febrile seizures associated with 
the administration of MMRV vaccines.85 Scientific studies, however, have shown 
that concerns with adverse events resulting from the simultaneous administration of 
vaccines to be  “unfounded.”86 “The immune systems of infants and children en-
counter millions of antigens in their environment every day; vaccines only contain 
a tiny fraction of a typical child’s daily exposure to antigens.”87 
2. The Case of Vaccine Staggering 
As indicated above, in this Essay we introduce the expression “vaccine stag-
gering” to refer to departures from vaccination schedules (delays in receiving one 
or more vaccines) motivated by the desire to boost the efficacy of each vaccine 
received by a child or adult. Omer and others have described this phenomenon in 
the following way: 
Instead of refusing vaccines, some parents delay vaccination of their children. 
Many parents follow novel vaccine schedules proposed by individual physicians 
(rather than those developed by expert committees with members representing 
 
 79. Vaccine Safety: Multiple Vaccinations at Once, CTRS. DISEASE CONTROL & PREVENTION, 
MULTIPLE VACCINES AND THE IMMUNE SYSTEM, https://www.cdc.gov/vaccinesafety/concerns/multi-
ple-vaccines-immunity.html (last reviewed August 14, 2020). 
 80. See Vaccines for Your Children: Combination Vaccines, supra note 78. 
 81. Do Combination Vaccines or Simultaneous Vaccination Increase the Risk of Adverse Events?,  
INST. VACCINE SAFETY, http://www.vaccinesafety.edu/vs-combo.htm#*_ (last updated May 10, 2018). 
 82. Id. An example of a combination vaccine is the MMRV (measles, mumps, rubella and varicella 
vaccine). See Vaccine Information Statements (VISs): MMRV (Measles, Mumps, Rubella & Varicella) 
VIS, CTRS. DISEASE CONTROL & PREVENTION, V (2019), https://www.cdc.gov/vaccines/hcp/vis/vis-
statements/mmrv.html (last reviewed August 15, 2019). The guidelines further caution that [t]These 
conclusions do not necessarily consider vaccines recommended only for special populations in the 
United States such as Yellow Fever vaccine (international travelers) or Smallpox vaccine (military per-
sonnel).” Id. 
 83. See Do Combination Vaccines or Simultaneous Vaccination Increase the Risk of Adverse Events?, 
supra note 81. 
 84. See Id.; Katrin S. Kohl et al., Fever after Immunization: Current Concepts and Improved Future 
Scientific Understanding, 39 CLINICAL INFECTIOUS DISEASES, 389, 890 (2004). 
 85. See Vaccine Information Statements (VISs): MMRV (Measles, Mumps, Rubella & Varicella) VIS, 
supra note 82. 
 86. See Do Combination Vaccines or Simultaneous Vaccination Increase the Risk of Adverse Events?, 
supra note 81. 
 87. Id. 
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multiple disciplines). Most novel schedules involve administering vaccines over a 
longer period than that recommended by the Advisory Committee on Immunization 
Practices and the American Academy of Pediatrics or skipping the administration 
of some vaccines.”88 
The “novel vaccine schedules” described by Omer and others are also known 
as “alternative” vaccination schedules, both in the United States and abroad.89 Be-
fore explaining why we think the proliferation of these alternative timelines for vac-
cination warrant greater study and institutional attention, we would like to reiterate 
that the practice of vaccine staggering, currently subsumed into hesitancy frame-
works, is at odds with existing guidance from scientific and regulatory bodies alike. 
As such, the arguments we make here are not in favor of vaccine staggering as a 
practice, but rather in favor of (1) building a better and more granular vaccine data 
infrastructure that will help scientific and regulatory bodies deal with this particular 
form of vaccine hesitancy in more comprehensive ways; and (2) recognizing that, 
given the current polarization of debates on vaccine-related themes, it is poor policy 
to address the behavior of adults who wish to receive recommended vaccines but 
stagger their administration (or wish their children to receive all recommended 
childhood vaccines according to a staggered timeline) in the same way that vaccine 
rejection and vaccine delays motivated by other reasons are addressed. 
Moreover, we submit here that the term “alternative schedules” should not be 
used in connection with the practice of vaccine staggering. Vaccination schedules 
are regulatory and public health tools. Departures from the schedule—even if based 
on concerns with the efficacy of vaccines—do not amount to either. In fact, our 
argument is that these departures illustrate scientific and regulatory holes in our 
vaccination infrastructure,90 and as such the emphasis should be on addressing the 
underlying problems leading to departures from schedules, rather than elevating 
ongoing vaccination practices —with relevance, but in circumvention of medical 
consensus and regulatory mandates—to schedule-like status. 
We propose that the practices that are now often described as adherence to an 
“alternative schedule” be regarded as vaccine staggering. This expression speaks to 
the deliberate intention of having vaccines administered over a longer period of time 
when compared to the ones established by vaccination schedules issued by scien-
tific and regulatory bodies. Vaccine staggering is distinguishable from other types 
of delays in the administration of a recommended vaccine. For instance, a delay 
may be prompted by temporary, health-related circumstances, such as the indicated 
patient for a specific vaccine having a moderate or severe illness91 or being preg-
nant.92 This situation is materially different from the decision of a parent or physi-
cian to stagger vaccination across a period of time because of concerns with reduced 
 
 88. Omer, supra note 45. 
 89. See Id. 
 90. Infra, Part III.C. 
 91. See Vaccine Recommendations and Guidelines of the ACIP: Contraindications and Precautions,  
CTRS. DISEASE CONTROL & PREVENTION, CONTRAINDICATIONS AND PRECAUTIONS, 
https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html (last reviewed No-
vember 17, 2020) (“Vaccination should be deferred for persons with a moderate or severe acute ill-
ness.”). 
 92. Id. (“[W]omen known to be pregnant generally should not receive live, attenuated virus vac-
cines”). 
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immunogenicity93—the practice we label staggering. Moreover, as noted above, 
staggering vaccination is fundamentally different from delaying vaccination, due to 
reliance on vaccine misinformation such as the belief that vaccines are generally 
unsafe,94 or that vaccination campaigns are political, governmental or ideological 
tools. 
Vaccine staggering gained popularity in the second decade of the twenty-first 
century. One of the most influential proponents of “alternative schedules” is Dr. 
Robert Sears (commonly known as Dr. Bob) whose book, The Vaccine Book: Mak-
ing the Right Decision for Your Child, was published by one of the largest literary 
publishers, Hachette.95 The book quickly became extremely popular. At the time of 
writing, the book had over 3,600 ratings and over 490 reviews on Goodreads, with 
an average score of 4.17 out of 5.96 
Among several arguments, Dr. Sears’s book advocated for the practice of vac-
cine staggering and offered specific “alternative vaccine schedules” to be used in 
lieu of the schedules developed and endorsed by advisory scientific bodies and reg-
ulators.97 It is worth underscoring the fact that these specific recommendations—as 
well as the bulk of Dr. Sears’ arguments—are directed at parents, not to audiences 
in the scientific and peer-review worlds.98 And the book has been successful in 
reaching its intended audience, with many parents now asking pediatricians to “that 
their children receive vaccines according to Sears’ schedule, rather than that recom-
mended by the American Academy of Pediatrics, the Centers for Disease Control 
and Prevention, and the American Academy of Family Physicians.”99 As leading 
commentators like Offit and Moser have noted, there are many problematic features 
in Dr. Sears’ book,100 including the suggestion that parents may make better deci-
sions for their children if they become familiar with non-scientific literature chal-
lenging recommendations concerning vaccination issued by scientific bodies and 
public health-oriented agencies.101 
 
 93. Immunogenicity has been defined as “the ability of a molecule or substance to provoke an immune 
response” and “the strength or magnitude of an immune response.” Siddhartha Mahanty et al., Immuno-
genicity of Infectious Pathogens and Vaccine Antigens, 16 BMC IMMUNOL. 31, 31 (2015). 
 94. See Sarah Geoghegan et al., Vaccine Safety: Myths and Misinformation, 11 FRONT. MICROBIOL. 
372 (2020). 
 95. The Vaccine Book: Making the Right Decision for Your Child, HACHETTE, https://www.hachette-
bookgroup.com/titles/robert-w-sears-md/the-vaccine-book/9780316213639/; Global Publishing Lead-




 96. GOODREADS, THE VACCINE BOOK: MAKING THE RIGHT DECISION FOR YOUR CHILD, 
https://www.goodreads.com/book/show/779230.The_Vaccine_Book. 
 97. See Melody Gutierrez, Dr. Bob Sears’ Views on Vaccines Have Inspired Loyal Followers — And 
a Crush of Criticism, L.A. TIMES (Sept. 3, 2019), https://www.latimes.com/california/story/2019-09-
02/bob-sears-controversial-views-on-vaccines-inspire-critics-and-fans. 
 98. See Id. 
 99. Paul A. Offit & Charlotte A. Moser, The Problem With Dr Bob’s Alternative Vaccine Schedule, 
123:1 PEDIATRICS e164, e164 (2009). 
 100. Offit and Moser’s criticism of the arguments in the book include Dr. Sear’s argument that “doctors 
do not know much about vaccines and that if parents educate themselves they will know more than their 
doctors,” “cast[ing] doubt on the reliability and motives of the CDC and pharmaceutical companies,” 
minimizing the importance of vaccine-preventable diseases, implying links between vaccination and the 
proliferation of chronic diseases, and casting doubts over the sufficiency of vaccine safety testing . Id. 
 101. Id. 
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While Dr. Sears remains the most influential proponent of a specific temporal 
departure from official vaccination schedules, even after being put on a 35-month 
probation by the Medical Board of California for writing a vaccine exemption with-
out obtaining the child’s vaccine records,102multiple schedules are easily located 
online and offline. By 2013, a study reported that more than one in ten parents com-
municated to their pediatrician the intention “to follow an alternative immunization 
schedule for their child.”103 
Currently, the best available scientific evidence indicates that no form of non-
medical departure from official vaccine schedules should occur, as both lack of vac-
cination and delayed vaccination increase the risk of the occurrence of an infectious 
disease.104 In line with our previous arguments about the overall need for greater 
granularity in addressing problems in this field, we note here that there is a need for 
more data on the different rationales behind current parental preferences for vaccine 
staggering,105 as well as more scientific data on the effects of staggering. With re-
gard to the latter point, commentators have often noted that “[t]he consequences of 
delayed vaccination, as compared with vaccine refusal, have not been studied in 
detail.”106 
There is scientific literature focusing on the impacts of concomitant versus 
staggered vaccine provision on immune responses in humans. These data are gen-
erally limited by small sample sizes and extraneous biases. Critically, this literature 
on live and inactivated vaccine provision is highly discordant, suggesting that the 
scientific community still has an extremely limited understanding of the impacts of 
the immune response after vaccine provision. Several studies suggest an immune 
negative interference with some concomitant vaccines,107 while others indicate no 
difference in immune response with concomitant vaccine provision.108 Therefore, 
arguments for or against staggering cannot be validated or disputed at this time. 
In other words, we have reliable data on vaccination practices as they related 
to official schedules, as well as data indicating that departures from the schedule 
increase the risk of infectious disease—by contrast, there is very limited data on 
staggered vaccination, almost exclusively centered on pediatric populations (thus 
disregarding adult ones). 
 
 102. See Soumya Karlamangla, California Doctor Critical of Vaccines is Punished For Exempting 2-
Year-Old Boy from All Childhood Immunizations, L.A. TIMES (Jun. 29, 2018), 
https://www.latimes.com/local/california/la-me-ln-sears-license-20180629-story.html. 
 103. See Wheeler, supra note 71; Adrianna Saada et al., Parents’ Choices and Rationales for Alterna-
tive Vaccination Schedules: A Qualitative Study, 54:3 CLIN. PEDIATR. 236, 236 (2015). 
 104. See Salmon, supra note 47. 
 105. See Hagood, supra note 60. 
 106. See Omer et al., supra note 45, at 1983. 
 107. See generally. J. Labadie et al., RIVM Report 124001003: Part 1. Immunogenicity, NAT’L INST. 
PUBLIC HEALTH & ENVIRONMENT (April 1996), https://www.rivm.nl/bibliotheek/rappor-
ten/124001003.pdf; Daniel E. Park et al., The Differential Impact of Coadministered Vaccines, Geo-
graphic Region, Vaccine Product and Other Covariates on Pneumococcal Conjugate Vaccine Immuno-
genicity, 33 PED. INFECT. DIS. J. S130, S132 (2014); D. M. Emperador et al., Interference of Monovalent, 
Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in 
Rural Bangladesh, 62 CLIN. INFECT. DIS. 150, 153 (2016). 
 108. Particularly for non-live vaccines. See generally Julia H. Leung et al., Immunogenicity and Reac-
togenicity of Tetravalent Vaccine for Measles, Mumps, Rubella And Varicella (MMRV) In Healthy Chil-
dren: A Meta-Analysis Of Randomized Controlled Trials, 14 EXPERT REV. VACCINES 1149 (2015); T. 
Nolan et al., Safety and Immunogenicity of Concurrent Administration of Live Attenuated Influenza Vac-
cine with Measles-Mumps-Rubella and Varicella Vaccines to Infants 12 to 15 Months of Age, 121 
PEDIATRICS 508, 508 (2008). 
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To be clear, our point is two-fold: first, no other schedules should at this point 
be considered other than the ones issued by the CDC and state regulatory authori-
ties, and adults (including parents deciding on behalf of their children) should com-
ply with vaccination schedules if there are no medical reasons to skip or delay the 
administration of a vaccine. And second: at the same time, we advocate for the pro-
duction of more data around the phenomenon of staggering, even if those data lead 
to complete disproval of any claims of staggering. Given the prominence of so-
called “alternative vaccination schedules” and consequent parental deviation from 
official schedules, we submit that regulators and advisory bodies should prioritize 
the acquisition of deeper knowledge on the reasons behind staggering, as well as 
scientific data on departures from official vaccination schedules—and we submit 
that a strategic approach to vaccine staggering on the part of regulators and policy-
makers is long overdue. Ignoring the specificities of vaccine staggering from a reg-
ulatory perspective—the current status quo—fuels uncertainty and conflicting dis-
courses outside the scientific arena at a time in which outbreaks of vaccine-prevent-
able disease are on the rise.109 
While accruing more data on the scientific aspects of staggering should consti-
tute an immediate priority, we also point out that recommendations and other treat-
ments of vaccination themes by regulators and advisory bodies should start ac-
knowledging the material differences between staggering and vaccine refusal, as 
well as between staggering and other forms of delays in vaccination. Parental con-
cerns with immunogenicity associated with the administration of a vaccine have a 
health-related dimension, rooted in the belief that staggering will maximize the im-
mune response triggered by a vaccine.110 Yet, this type of departure from vaccina-
tion schedules is not contemplated, with staggering being lumped together with ac-
tual instances of hesitancy, and occasionally with vaccine refusal. This is something 
that both our regulatory system and the vaccine-related vocabulary fail to 
acknowledge. 
To sum up, the now entrenched phenomenon of parents actively seeking tem-
poral departures from official vaccination schedules is one the reasons we need con-
certed policy and regulatory interventions in the area of vaccine staggering. A sec-
ond reason is the current lack of conceptual clarity at the regulatory and policy lev-
els, which either lumps or conflates this very specific behavior with behaviors that 
have nothing to do with the desire to increase the immunological response triggered 
by the administration of a vaccine. A third reason is the current lack of information 
surrounding the manifold motivations behind vaccine staggering, which is needed 
to enable more persuasive policy and regulatory interventions targeting individuals 
and communities who engage in vaccine staggering in a data-starved environment. 
And, relatedly, a fourth reason is the current lack of these data—granular scientific 
information on the effects of vaccine staggering—which is critical for the calibra-
tion of current approaches. 
 
 109. See Katherine F. Smith et al., Global Rise in Human Infectious Disease Outbreaks, 11 J. ROYAL 
SOC’Y INTERFACE 1 at 1 (2014), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223919/. 
 110. See generally Paul A. Offit et al., Addressing Parents’ Concerns: Do Multiple Vaccines Over-
whelm or Weaken the Infant’s Immune System?, 109 PEDIATRICS 124, 125 (2002). 
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C. Vaccine Staggering as an Embodiment of Larger Data In-
frastructure Problems 
The phenomenon of vaccine staggering illustrates problems that occur at a 
more systemic level in the vaccine ecosystem in the United States. We briefly dis-
cuss these connections here, incorporating some of the arguments we have made in 
the specific context of staggering into larger considerations about shortcomings of 
the vaccine data infrastructure in the United States. 
First, the conceptual problem identified with regard to vaccine staggering af-
fects other areas in vaccine policy and regulation. As seen above, the concept(s) of 
vaccine hesitancy commonly used are overly heterogenous and imprecise. From a 
regulatory perspective, our system does not distinguish—as it should—between de-
lays in the provision of vaccines and vaccine refusal.111 At a time of growing lack 
of confidence in vaccination as a crucial public health tool, this irresponsiveness of 
the regulatory system is particularly troubling. 
Second, the current (and continued) lack of scientific and socio-behavioral in-
formation surrounding vaccine staggering feeds into a larger patchwork problem in 
our vaccine data infrastructure. Most ongoing research on issues related to vaccine 
hesitancy is predominantly focused on parental behavior.112 By narrowing the pro-
duction of data primarily to these situations, we are neglecting the adult population 
in general, which constitutes the majority of the United States population. Adults 
have many recommended and/or required vaccines and with the dearth of scientific 
study of hesitancy in this population, interventions cannot be effectively developed 
and implemented. 
Third, and relatedly, data related to vaccine administration in the United States 
is not collected in any national repository and are solely maintained in the providing 
healthcare systems electronic health record.113 Therefore, it is impossible to track, 
evaluate, or improve vaccination rates in the overall population. To impact this area, 
a robust, preferably national, immunization data system is necessary. 
While these larger problems exceed the scope of this Essay, taking the neces-
sary steps to address sectoral problems within the vaccine ecosystem in the United 
States is overdue. 
 
 111. See generally Improving Vaccination Demand and Addressing Hesitancy, supra note 69; William 
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1 (2018). 
 113. See generally Meena Khare et al., Assessment of Immunization Registry Databases as Supple-
mental Sources of Data to Improve Ascertainment of Vaccination Coverage Estimates in the National 
Immunization Survey, 160 ARCH PEDIATR ADOLESC MED. 838, 841 (2006). 
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IV. CONCLUSION 
Although vaccines are among the most cost-effective and successful public 
health interventions for the preventions of infectious diseases, vaccine confidence 
across the United States has declined in recent years. Part of this decline is con-
nected to behaviors widely defined as vaccine-hesitant, a term that has come to des-
ignate a departure from vaccination schedules sanctioned by public health authori-
ties. In this essay, we have made the case that a subset of these departures—vaccine 
staggering—should be treated separately. Doing so would contribute to reduce con-
fusing and conflicting discourses, as well as to more accurately reflect the current 
heterogeneity in vaccine-related behaviors. 
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